DOASENSE
LIVE

Serial Number

79202682

Owner

DOASENSE GmbH

Attorney

Michael S. Hargis

Filing Date

Mar 9, 2016

Add to watchlist:

No watchlists yet
View on USPTO

DOASENSE Trademark

Serial Number: 79202682 • Registration: 5388823

DOASENSE is a trademark filed by DOASENSE GmbH on March 9, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

DOASENSE GmbH (2 trademarks)

Waldhofer Straße 102

Entity Type: 99

Trademark Details

Filing Date

March 9, 2016

Registration Date

January 30, 2018

Published for Opposition

November 14, 2017

Goods & Services

Reagents, test strips for urine analysis and for medical [ and veterinary ] purposes; test strips for determining substances in body fluids, namely, urine, for laboratory use, for use by doctors *;* [ , and for use by patients; pharmaceutical and veterinary preparations, namely, anticoagulants; sanitary preparations for medical use; chemical preparations for medical use, namely, for prevention and treatment of thromboembolic diseases; ] chemical reagents for medical use; [ chemical reagents for veterinary use; diagnostic media for medical use in the form of strips for measuring anticoagulant levels; diagnostic media for veterinary use in the form of strips for measuring anticoagulant levels; [ enzyme preparations for medical use; enzyme preparations for veterinary use; ] reagent paper for medical [ or veterinary ] use; medicated serums for treatment of blood vessels; ] test kits for medical use, namely, diagnostic test kits and drug test kits comprised of medical diagnostic assays for testing body fluids; urine test strips, namely, medical diagnostic test strips for urine analysis

[ Medical research; biological research; clinical research in the field of cardiovascular disease; medical and pharmaceutical research services; conducting analyses of urine for medical research purposes; information regarding medical and scientific research results relating to medicines and clinical examinations in the field of clinical trials, pharmaceuticals, and in vitro tests; providing information and data featuring medical research and development in the field of haematology; industrial analysis and research services in the field of in vitro testing; design and development of computer hardware and software; services of a chemical laboratory; research in the field of chemistry; clinical trial series, namely, conducting clinical trials for others; scientific laboratory services; laboratory analysis in the field of medical measurement readings; computer software programming for the evaluation and calculation of medical data ]

[ Providing medical urine tests; medical diagnostics testing services; veterinary diagnostics testing services; medical services; veterinary services; telemedicine services ]

Chemical and biochemical [ and biological ] preparations for commercial and scientific purposes, namely, chemical preparations for use in industry and diagnostic preparations for scientific use; control reagents for use with scientific apparatus and instruments for research purposes

[ Urine testing cups for drug use testing purposes; urine testing glasses for drug use testing purposes; medical bags for collecting and storing urine samples; urinals for medical use; urine drainage bags for medical purposes; urinary flow monitors; medical urinals being vessels for medical purposes; surgical apparatuses and instruments; medical apparatuses and instruments, namely, apparatuses for medical diagnostic anticoagulant testing; analytical apparatus for medical use for analyzing blood, saliva, and urine; blood analyzing apparatus; diagnostic apparatus for testing anticoagulant levels; examination and surveying apparatus for medical use, namely, medical imaging apparatus; medical urine examination apparatus for medical diagnosis ]

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jun 9, 2026 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 30, 2026 INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 28, 2026 INPS
INVALIDATION PROCESSED
May 28, 2026 INPC
INTERNATIONAL REGISTRATION RENEWED
Mar 12, 2026 RNWL
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 11, 2025 INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 7, 2025 INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 6, 2025 INPR
REGISTERED - SEC. 7 REQUEST ABANDONED
Sep 30, 2025 PRA7
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Sep 30, 2025 PRAN
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 21, 2025 APRE
TEAS SECTION 7 REQUEST RECEIVED
Jun 1, 2025 ES7R
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 11, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Apr 11, 2025 71.P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Mar 6, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Mar 6, 2025 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 6, 2025 APRE
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 28, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 28, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 28, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 28, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 28, 2024 REAP
TEAS SECTION 71 RECEIVED
Nov 7, 2023 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 30, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 6, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 8, 2018 FICS
FINAL DISPOSITION PROCESSED
May 8, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 6, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 4, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 4, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 4, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 4, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2017 CRFA
ASSIGNED TO LIE
Sep 19, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 13, 2017 TROA
REFUSAL PROCESSED BY IB
Apr 8, 2017 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2017 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2017 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2017 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Mar 17, 2017 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 16, 2017 RFCR
NON-FINAL ACTION WRITTEN
Mar 15, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 14, 2017 MAFR
ASSIGNED TO EXAMINER
Mar 10, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2017 REPR